Business Context and Reporting Period
Company: Nature's Sunshine Products, Inc. (NATR)
Filing Type: Form 10-Q (Unaudited)
Reporting Period: Quarter and nine months ended September 30, 2025
Business Overview: A natural health and wellness company manufacturing and selling nutritional and personal care products via a direct selling model of independent consultants. Operations are segmented geographically into Asia, Europe, North America, and Latin America/Other.
Key Financial Metrics
| Metric (in thousands) | Q3 2025 | Q3 2024 | 9M 2025 | 9M 2024 |
|---|---|---|---|---|
| Net Sales | $128,339 | $114,615 | $356,337 | $336,159 |
| Gross Profit | $94,049 | $81,759 | $257,945 | $239,624 |
| Gross Margin | 73.3% | 71.3% | 72.4% | 71.3% |
| Operating Income | $8,975 | $5,284 | $19,421 | $15,545 |
| Net Income (Total) | $5,535 | $4,646 | $15,938 | $8,624 |
| Net Income (Common Shareholders) | $5,334 | $4,347 | $15,414 | $8,017 |
| Diluted EPS | $0.30 | $0.23 | $0.83 | $0.42 |
| Cash and Equivalents | $95,554 | $84,700 | $95,554 | $78,704 |
| Operating Cash Flow (9M) | $25,423 | $13,114 | ||
| Debt (Revolving Credit) |
Liquidity: Working capital increased to $102.4 million as of September 30, 2025, from $94.9 million at year-end 2024. The company maintains a $25.0 million revolving credit facility with no outstanding balance as of the reporting date.
Material Changes vs. Prior Period
- Revenue Growth: Q3 2025 net sales increased 12.0% ($13.7M) year-over-year. Excluding foreign currency impacts, sales grew 10.5%. Growth was driven by Asia (+17.1%), Europe (+12.7%), and North America (+7.7%), partially offset by a decline in Latin America/Other (-13.1%).
- Profitability Expansion: Operating income surged 69.9% in Q3 2025 to $8.975M. Gross margin improved to 73.3% from 71.3% due to cost savings initiatives, favorable market mix, and foreign exchange benefits.
- Expense Management: SG&A expenses increased 11.7% in Q3, primarily due to timing of compensation, digital marketing investments, and consultant events. Volume incentives remained stable as a percentage of sales (30.7% vs 31.0%).
- Foreign Exchange: Significant foreign exchange gains of $0.672M in Q3 and $4.451M for the nine months ended September 30, 2025, contributed to "Other income, net."
- Share Repurchases: The company repurchased 1,129,000 shares for $14.4 million during the first nine months of 2025. As of September 30, $19.3 million remained available under the repurchase program.
Guidance, Outlook, and Risks
Management Commentary:
- China Joint Ventures: On June 30, 2025, the company entered agreements to purchase Fosun Industrial's interest in two Chinese joint ventures for $7.0 million total ($3.9M and $3.1M). This transaction is subject to regulatory approval and will result in sole ownership by Nature's Sunshine.
- Trade Compliance: The company voluntarily disclosed potential trade control violations to the U.S. Department of Commerce (BIS) and OFAC in September 2025. Management estimates these violations represented less than 1% of net revenue over the last three years and does not expect fines to be material, though outcomes remain uncertain.
- Tariffs: While higher tariffs have begun affecting costs in 2025, the full-year impact is not expected to be material. The company is monitoring raw material availability and pricing.
- Eastern Europe: Operations in Ukraine and Russia continue at reduced levels due to ongoing conflict. Net sales in this region were $13.9M for Q3 2025.
Risks and Contingencies:
- Legal: Accrued liabilities for legal proceedings were $0.7 million. Potential future payments could range from $0 to $2.9 million.
- Tax: The effective tax rate for the nine months ended September 30, 2025, was 34.5%, lower than the prior year's 49.2%, due to a decrease in foreign losses and favorable valuation allowance adjustments.
- Market Risk: Significant exposure to foreign currency fluctuations and geopolitical instability affecting international supply chains and sales.
Investor Verification Checklist
- China JV Closing: Verify the regulatory approval status and closing date for the $7.0 million acquisition of Fosun's interest in the Chinese joint ventures.
- Trade Compliance Outcome: Monitor the resolution of the voluntary self-disclosures to BIS and OFAC regarding trade control violations to assess potential fines or operational restrictions.
- FX Sensitivity: Evaluate the sustainability of the $4.45M foreign exchange gain in the nine-month period, as this significantly boosted net income.
- Inventory Levels: Review the increase in inventory to $67.3M (from $59.4M at year-end 2024) to ensure it aligns with sales growth and does not indicate obsolescence risks.
- Share Count: Confirm the impact of the $14.4M share repurchase program on future earnings per share dilution/accretion.